➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Mallinckrodt
Boehringer Ingelheim
AstraZeneca
McKinsey

Last Updated: June 15, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018911


Email this page to a colleague

« Back to Dashboard

NDA 018911 describes HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%, which is a drug marketed by Hospira and is included in two NDAs. It is available from two suppliers. Additional details are available on the HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% profile page.

The generic ingredient in HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% is heparin sodium. There are seventy-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 018911
Tradename:HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%
Applicant:Hospira
Ingredient:heparin sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/100ML
Approval Date:Jan 30, 1985TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength100 UNITS/ML
Approval Date:Jan 30, 1985TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10,000 UNITS/100ML
Approval Date:Jan 30, 1985TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Medtronic
Moodys
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.